Flibanserin de la serie del aumento del sexo de las materias primas farmacéuticas para el aumento del músculo 167933-07-5
Abstracto
CASO:167933-07-5
MF:C20H21F3N4O
MW:390.4
EINECS:1806241-263-5
temperatura de almacenamiento. 2-8° C
solubilidad DMSO: soluble10mg/mL, Solución antibacteriana necesaria en alcohol bencílico de aceite esteroide
color blanco a beige
Hazard statements H301-H315-H319-H335
Precautionary statements P261-P301+P310-P305+P351+P338
Hazard Codes T
Declaraciones de riesgo 25-36/37/38
Declaraciones de seguridad 26-45
Descripción
Flibanserin is used for hypoactive sexual desire disorder among women. Those receiving flibanserin report a 0.5 increase compared to placebo in the number of times they had “satisfying sexual events”.In those on flibanserin it rose from 2.8 a 4.5 times a month while women receiving placebo reported also an increase of “satisfying sexual events” from 2.7 a 3.7 times a month.The onset of the flibanserin effect was seen from the first timepoint measured after 4 weeks of treatment and maintained throughout the treatment period.
The effectiveness of flibanserin was evaluated in three phase 3 clinical trials. Each of the three trials had two co-primary endpoints, one for satisfying sexual events (SSEs) and the other for sexual desire. Each of the 3 trials also had a secondary endpoint that measured distress related to sexual desire.
Solicitud
Flibanserin is used for hypoactive sexual desire disorder among women. Those receiving flibanserin report a 0.5 increase compared to placebo in the number of times they had “satisfying sexual events”. In those on flibanserin it rose from 2.8 a 4.5 times a month while women receiving placebo reported also an increase of “satisfying sexual events” from 2.7 a 3.7 times a month.The onset of the flibanserin effect was seen from the first timepoint measured after 4 weeks of treatment and maintained throughout the treatment period.
COA
| Testing Items |
Especificaciones |
Resultados |
| Characteristics |
An off-white to white powder |
Complied |
| Identificación |
Meet the requirements |
Positivo |
| Loss on Drying |
≤0.50% |
0.13% |
| Metales pesados |
≤20PPM |
<20PPM |
| Pureza (por HPLC) |
≥99,0% |
99.2% |
| Conclusión: |
The commodity is complied with the standard of the factory |
1. Hot sales
| Acetato de testosterona |
Acetato de trembolona |
T-A001 MGF 2mg |
| Cipionato de testosterona |
Enantato de trembolona |
T-A002 PEG MGF 2mg |
| Decanoato de testosterona |
Acetato de boldenona |
T-A003 CJC-1295 with DAC 2mg |
| Enantato de testosterona |
Undecilenato de boldenona |
T-A004 CJC-1295withoutDAC 2mg |
| Isocaproato de testosterona |
Cipionato de boldenona |
T-A005 PT-141 10mg |
| Fenilpropionato de testosterona |
Propionato de boldenona |
T-A006 MT-1 10mg |
| Propionato de testosterona |
Decanoato de nandrolona |
T-A007 MT-2 10mg |
| Undecanoato de testosterona |
Fenilpropionato de nandrolona |
T-A008 GHRP-2 5mg |
| Mesterona |
Undecilato de nandrolona |
T-A009 GHRP-6 5mg |
| Sustanon de testosterona 250 |
Cipionato de nandrolona |
T-A009 GHRP-6 10mg |
| Acetato de clostebol |
Propionato de nandrolona |
T-A010 Ipamorelin 2mg |
| Metilandrostanolona |
Metiltrienolona |
T-A011 Hexarelin 2mg |
| Enantato de metenolona |
Propionato de drostanolona |
T-A012 Sermorelin 2mg |
| Acetato de metenolona |
Enantato de drostanolona |
T-A013 Oxytocin 2mg |
| Anadrol |
Stanolone |
T-A014 TB500 2mg |
| Anavar |
Tadalafil |
T-A015 pentadecapeptide BPC 157 2mg |
| Winstrol |
Vardenafilo |
T-A016 GH 176-191 2mg |
| Citrato de clomifeno |
Dianabol |
T-A017 Triptorelin 2mg |
| Citrato de toremifeno |
Citrato de tamoxifeno |
T-A018 Tesamorelin 2mg |
| Finasterida |
clorhidrato |
T-A020 Gonadorelin 2mg |
| T-A022 Selank 5mg |
T-A021 DSIP 2mg |
T-A020 Gonadorelin 10mg |
Gerente de ventas